As of 2026-09-16, the Relative Valuation of Cardiol Therapeutics Inc (CRDL.TO) is (2.85) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 2.77 CAD, the upside of Cardiol Therapeutics Inc based on Relative Valuation is -202.8%.
The range of the Relative Valuation is (2.35) - (3.31) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.0x - 10.5x | 8.8x |
| Forward P/E multiples | 7.4x - 11.2x | 9.3x |
| Fair Price | (2.35) - (3.31) | (2.85) |
| Upside | -184.7% - -219.6% | -202.8% |
| Date | P/E |
| 2026-09-14 | -8.78 |
| 2026-09-11 | -8.72 |
| 2026-09-10 | -8.78 |
| 2026-09-09 | -10.02 |
| 2026-09-08 | -9.70 |
| 2026-09-04 | -9.67 |
| 2026-09-03 | -9.45 |
| 2026-09-02 | -9.54 |
| 2026-09-01 | -9.61 |
| 2026-08-31 | -8.72 |
| 2026-08-28 | -8.56 |
| 2026-08-27 | -9.10 |
| 2026-08-26 | -9.42 |
| 2026-08-25 | -8.75 |
| 2026-08-24 | -8.18 |
| 2026-08-21 | -8.18 |
| 2026-08-20 | -8.27 |
| 2026-08-19 | -8.56 |
| 2026-08-18 | -8.27 |
| 2026-08-17 | -7.89 |
| 2026-08-14 | -7.96 |
| 2026-08-13 | -7.67 |
| 2026-08-12 | -6.72 |
| 2026-08-11 | -6.69 |
| 2026-08-10 | -6.53 |
| 2026-08-07 | -6.31 |
| 2026-08-06 | -6.12 |
| 2026-08-05 | -6.02 |
| 2026-08-04 | -6.09 |
| 2026-07-31 | -5.58 |
| 2026-07-30 | -5.42 |
| 2026-07-29 | -5.17 |
| 2026-07-28 | -5.39 |
| 2026-07-27 | -5.20 |
| 2026-07-24 | -5.29 |
| 2026-07-23 | -5.52 |
| 2026-07-22 | -5.77 |
| 2026-07-21 | -5.61 |
| 2026-07-20 | -5.55 |
| 2026-07-17 | -5.36 |
| 2026-07-16 | -5.52 |
| 2026-07-15 | -5.01 |
| 2026-07-14 | -5.17 |
| 2026-07-13 | -4.76 |
| 2026-07-10 | -4.57 |
| 2026-07-09 | -4.63 |
| 2026-07-08 | -4.57 |
| 2026-07-07 | -4.66 |
| 2026-07-06 | -4.85 |
| 2026-07-03 | -4.85 |